An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma

NCT00738582 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Pleural Mesothelioma

Interventions

DRUG: MORAb-009 (Amatuximab)
DRUG: Pemetrexed
DRUG: Cisplatin

Sponsor

Morphotek